WeRoaM: Wearable Remote Monitoring in Heart Failure

Who May Qualify: - Patients from 8-18 years of age who are outpatients at time of study enrollment. - Patients with a chest size of at least 69.85 cm in perimeter/circumference (as measured under the pectoral muscles) - Patients at-risk for heart failure and with American Heart Association (AHA) Stage B-D Heart Failure will be included in this study irrespective of heart failure medication use. - HF etiologies include: congenital cardiac malformation with systemic ventricular systolic dysfunction, idiopathic cardiomyopathy, familial/inherited and/or genetic cardiomyopathy, history of myocarditis with persistent ventricular dysfunction, neuromuscular disorder, inborn error of metabolism, mitochondrial disorder, acquired (chemotherapy, iatrogenic, infection, rheumatic, or nutritional), ischemic (e.g., Kawasaki disease and post-operative HF), and left ventricular non-compaction, restrictive cardiomyopathy and HCM with systolic or diastolic dysfunction. Who Should NOT Join This Trial: - Patients within 3 months of a surgery. - Patients supported by ventricular assist device at study onset. - Inability to use technology due to physical or cognitive impairment in the patient or caregiver. - Non-English speaking. - Patients who have an implantable cardiac defibrillator or pacemaker - Patients whose chest size is too large or small to fit available sizes of the Skiin device. Always talk to your doctor about whether this trial is right for you.